OPERATIONS

We operate in multiple locations to ensure high service delivery and innovation. Our facilities in Greece, Lesotho and Southern Africa allow us great reach through the African continent, Europe and into Asia. We have access to 11,000 pharmacies, 35,000 doctors and 100 wholesalers in over 21 countries. We seek to improve the lives of as many people as possible, and are achieving this through a diversified location system.

Cannsun Medhel
Cannsun Medhel

Greece

  • 70,500 square foot EUGMP certified pharmaceutical manufacturing facility located in Athens, Greece. 
  • More than 150 SKU’s by year end 2020
  • Access to 11,000 pharmacies, 35,000 doctors & 100 wholesalers in Greece and sales to over 21 countries in Europe, Asia & Africa
  • Obtaining Schedule I License by Q2 2020 that will enable us to immediately batch release & distribute THC flower/concentrate and other narcotic classified products.
  • Large sales force in place with sales and distribution across Europe, Africa and Asia.
Cannsun Medhel

South Africa

Cape Town

  • Atlantis: 1 cultivation license pending, final inspection passed in December 2019.
  • 23 hectare property with 3.0 hectare   development planned for Phase 1.
  • Tunnels currently constructed on site with  flower processing facilities in place.
  • First grow cycle planned for Q1 2020
  • BBBEE complaint, increasing participation of South African labor in economic activities

 

Cannsun Medhel

Lesotho

  • Alpine: 1 cultivation license awarded, 1.5 hectare Phase 1 development, construction currently underway
    Maloti1 cultivation licence awarded, 2.0 hectare Phase 1 development, construction to H2 2020
  • BBBEE complaint, increasing participation of South African labor in economic activities

Asia

  • China: 2,000 sq meter production and CBD manufacturing facility under construction Q2 2020, facility will produce CBD for luxury cosmetics utilizing natural botanicals and European ingredients.
  • Thailand: 10 hectare hemp CBD cultivation located in Kohn Kaen, large facility will be constructed for the extraction and manufacturing of CBD cosmetics, skin care products, CBD coffee and nutraceuticals.
  • Malaysia: distribution of Cannsun Medhel products in Malaysia with application process in place to potentially distribute CBD products in late 2020
Scroll to Top